February 2026 in “International Journal of Clinical Pharmacy” This commentary described developing a framework to evaluate how pharmacists in community pharmacy care clinics impact emergency department visits, focusing on conditions they can manage, adverse medication events, and necessary referrals.
3 citations
,
February 2021 in “JAMA Dermatology” Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.
May 2026 in “JAAD International” This article notes the lack of US prevalence data for primary lymphocytic cicatricial alopecias due to the recent introduction of subtype-specific ICD-10 codes and highlights the importance of early diagnosis for hair preservation.
April 2024 in “Pharmacoepidemiology and drug safety (Print)” This study found that using at least one ICD-10 code for alopecia in Medicaid claims data accurately identified alopecia in women of childbearing age, with positive predictive values between 95.3% and 100% across various algorithms tested.
February 2024 in “Bőrgyógyászati és venerológiai szemle” This review presents possible classifications of psychological disorders that significantly impact dermatology, along with their clinical characteristics and comorbidities, highlighting lesions as potential warning signs based on DSM-5 and ICD-10 codes.
